ESOVYND – US Trademark 79145491 of Boehringer Ingelheim International GmbH

Trademark image

ESOVYND (U.S. Trademark Serial Number 79145491) is a United States trademark of Boehringer Ingelheim International GmbH. The goods and services include: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders . The correspondent is MARTIN J. BERAN of OSTROLENK FABER LLP.

This trademark was filed on February 10, 2014 as United States Trademark Application Serial Number 79145491. The trademark application was registered on September 30, 2014 as U.S. Trademark Registration 4611925.

Trademark PTO Status History

July 04, 2022 – TOTAL INVALIDATION PROCESSED BY THE IB

May 02, 2022 – TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

May 02, 2022 – INVALIDATION PROCESSED

December 16, 2021 – TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

April 16, 2021 – CANCELLED SECTION 71

March 13, 2015 – FINAL DECISION TRANSACTION PROCESSED BY IB

February 19, 2015 – FINAL DISPOSITION NOTICE SENT TO IB

February 19, 2015 – FINAL DISPOSITION PROCESSED

View full trademark status information at USPTO

Ownership History

Boehringer Ingelheim International GmbH

Boehringer Ingelheim International GmbH

Boehringer Ingelheim International GmbH

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.

Leave a Reply

Your email address will not be published. Required fields are marked *